betamethasone dipropionate + betamethasone sodium phosphate

Betamethasone dipropionate + betamethasone sodium phosphate is a combination of two synthetic glucocorticoid corticosteroids. Both are potent anti-inflammatory and immunosuppressive agents, but they differ in their solubility and pharmacokinetics. Betamethasone sodium phosphate is highly water-soluble, providing rapid onset of action, while betamethasone dipropionate (like the more commonly used acetate or other esters) is less soluble, resulting in a slower onset but prolonged duration of effect. This combination allows for both immediate and sustained suppression of inflammation and immune responses. The drug acts by binding to intracellular glucocorticoid receptors, modulating gene expression to suppress pro-inflammatory cytokines and mediators. It is primarily indicated for severe inflammatory conditions such as allergic reactions, dermatologic diseases, rheumatic disorders (e.g., arthritis), endocrine disorders (e.g., adrenal insufficiency), respiratory diseases (e.g., asthma exacerbations), gastrointestinal diseases (e.g., ulcerative colitis flares), blood disorders, eye conditions, kidney disease flare-ups, lupus flares, multiple sclerosis relapses, and certain cancers as supportive therapy[1][2][3][6]. The combination may be administered via injection when oral therapy is not feasible.

Brand names

DiprostèneDiprospanDiprofos

Other names

Betamethasone depotBetamethasone dipropionate, betamethasone sodium phosphate drug combination